SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-20-021896
Filing Date
2020-05-06
Accepted
2020-05-06 16:00:27
Documents
80
Period of Report
2020-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q akca-10q_20200331.htm 10-Q 2415560
2 EX-10.3 akca-ex103_138.htm EX-10.3 24368
3 EX-10.4 akca-ex104_137.htm EX-10.4 94916
4 EX-31.1 akca-ex311_6.htm EX-31.1 18964
5 EX-31.2 akca-ex312_11.htm EX-31.2 18974
6 EX-32.1 akca-ex321_9.htm EX-32.1 10827
7 GRAPHIC ggynzz0ij05e000001.jpg GRAPHIC 3366
8 GRAPHIC ggdpdm4uuny2000001.jpg GRAPHIC 4013
  Complete submission text file 0001564590-20-021896.txt   9032768

Data Files

Seq Description Document Type Size
9 XBRL INSTANCE DOCUMENT akca-20200331.xml EX-101.INS 2021381
10 XBRL TAXONOMY EXTENSION SCHEMA akca-20200331.xsd EX-101.SCH 74439
11 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE akca-20200331_cal.xml EX-101.CAL 61304
12 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE akca-20200331_def.xml EX-101.DEF 269249
13 XBRL TAXONOMY EXTENSION LABEL LINKBASE akca-20200331_lab.xml EX-101.LAB 487963
14 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE akca-20200331_pre.xml EX-101.PRE 391635
Mailing Address 22 BOSTON WHARF RD 9TH FLOOR BOSTON MA 02210
Business Address 22 BOSTON WHARF RD 9TH FLOOR BOSTON MA 02210 617-207-0202
AKCEA THERAPEUTICS, INC. (Filer) CIK: 0001662524 (see all company filings)

IRS No.: 472608175 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38137 | Film No.: 20852503
SIC: 2834 Pharmaceutical Preparations